Marshall Wace’s Dare Bioscience DARE Stock Holding History

Marshall Wace’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,140	Closed	-$110K	–	3499
2022 Q1	$110K	Sell	6,140 -109,574	-95%	-$2.07M	﹤0.01%	3186
2021 Q4	$2.78M	Buy	+115,714	New	+$2.38M	0.01%	1832

Other funds holding DARE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SAM

Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FFS

Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

FFA

Founders Financial Alliance Raleigh, North Carolina $555M AUM 22.31% 1-Year Est. Return

Marshall Wace's DARE Position: Q2 2022 in Review

Marshall Wace sold out of Dare Bioscience (DARE) in Q2 2022, closing a stake of 6,140 shares — an estimated $110K sold.

Marshall Wace first reported a position in DARE in Q4 2021 and held it in 2 quarters. The position peaked at $2.78M in Q4 2021. 36 funds tracked by Wall St. Rank hold DARE as of Q2 2022.

Marshall Wace reported no remaining Dare Bioscience position as of Q2 2022 after selling out during the quarter.
Marshall Wace sold 6,140 Dare Bioscience shares in Q2 2022, an estimated $110K.
Marshall Wace first reported a position in Dare Bioscience in Q4 2021 and held it in 2 quarters.
Marshall Wace's Dare Bioscience position peaked at $2.78M in Q4 2021.
36 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2022.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.